# Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD

> **NCT00141050** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 90 (—)

## Conditions studied

- ADHD

## Interventions

- **DRUG:** Focalin XR

## Key facts

- **NCT ID:** NCT00141050
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** —
- **Final completion:** 2005-07
- **Target enrollment:** 90 (—)
- **Last updated:** 2007-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00141050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00141050, "Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00141050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*